These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
584 related articles for article (PubMed ID: 36215392)
1. Seroprevalence of SARS-CoV-2 antibodies in vaccinated healthcare workers in Marrakech (Morocco). Ben Houmich T; Tali A; Debbagh F; Lamrani Hanchi A; Soraa N Int J Immunopathol Pharmacol; 2022; 36():3946320221133697. PubMed ID: 36215392 [TBL] [Abstract][Full Text] [Related]
2. Seroepidemiological assessment of SARS-CoV-2 vaccine responsiveness and associated factors in the vaccinated community of the Casablanca-Settat Region, Morocco. Ezzikouri S; Tajudeen R; Majidi H; Redwane S; Aqillouch S; Abdulaziz M; Aragaw M; Papa Fallah M; Sembuche S; Batcho S; Kabwe P; Gonese E; Laazaazia O; Elmessaoudi-Idrissi M; Meziane N; Ainahi A; Sarih M; Ogwell Ouma AE; Maaroufi A Sci Rep; 2024 Apr; 14(1):7817. PubMed ID: 38570577 [TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of anti-SARS-CoV-2 IgG antibodies pre- and post-COVID-19 vaccination in staff members of Bandar Abbas Children's Hospital. Tariverdi M; Mohammadi H; Hassanzadeh F; Tamaddondar M BMC Infect Dis; 2024 Feb; 24(1):253. PubMed ID: 38395759 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the effectiveness and duration of anti-RBD SARS-CoV-2 IgG antibody response between different types of vaccines: Implications for vaccine strategies. Sughayer MA; Souan L; Abu Alhowr MM; Al Rimawi D; Siag M; Albadr S; Owdeh M; Al Atrash T Vaccine; 2022 May; 40(20):2841-2847. PubMed ID: 35397946 [TBL] [Abstract][Full Text] [Related]
5. Durability of COVID-19 humoral immunity post infection and different SARS-COV-2 vaccines. Alroqi F; Barhoumi T; Masuadi E; Nogoud M; Aljedaie M; Abu-Jaffal AS; Bokhamseen M; Saud M; Hakami M; Arabi YM; Nasr A J Infect Public Health; 2024 Apr; 17(4):704-711. PubMed ID: 38479067 [TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of SARS-CoV-2 IgG Antibodies and Factors Associated with SARS-CoV-2 IgG Neutralizing Activity among Primary Health Care Workers 6 Months after Vaccination Rollout in France. Decarreaux D; Pouquet M; Souty C; Vilcu AM; Prévot-Monsacre P; Fourié T; Villarroel PMS; Priet S; Blanché H; Sebaoun JM; Deleuze JF; Turbelin C; Werner A; Kochert F; Grosgogeat B; Rabiega P; Laupie J; Abraham N; Guerrisi C; Noël H; Van der Werf S; Carrat F; Hanslik T; Charrel R; De Lamballerie X; Blanchon T; Falchi A Viruses; 2022 May; 14(5):. PubMed ID: 35632699 [TBL] [Abstract][Full Text] [Related]
7. Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine. Choi JH; Kim YR; Heo ST; Oh H; Kim M; Lee HR; Yoo JR Front Immunol; 2022; 13():827306. PubMed ID: 35173736 [TBL] [Abstract][Full Text] [Related]
8. Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19? Scaggs Huang F J Pediatric Infect Dis Soc; 2022 Apr; 11(4):126. PubMed ID: 35394545 [TBL] [Abstract][Full Text] [Related]
9. Antibody response after a third dose mRNA-1273 vaccine among vaccinated healthcare workers with two doses of inactivated SARS-CoV-2 vaccine. Cucunawangsih C; Wijaya RS; Lugito NPH; Suriapranata I Int J Infect Dis; 2022 May; 118():116-118. PubMed ID: 35192955 [TBL] [Abstract][Full Text] [Related]
10. Post-vaccination SARS-CoV-2 IgG spike antibody responses among clinical and non-clinical healthcare workers at a tertiary facility in Kenya. Mwangi LW; Omuse G; Adam R; Ong'ete G; Matheka C; Mugaine P; Sayed S; Maina D PLoS One; 2024; 19(4):e0299302. PubMed ID: 38573911 [TBL] [Abstract][Full Text] [Related]
11. [Humoral immunity against SARS-CoV-2 in workers of social health care centers of Castilla y León after vaccination with the BNT162b2 mRNA vaccine from Pfizer/Biontech.]. Casas Fischer R Rev Esp Salud Publica; 2021 Oct; 95():. PubMed ID: 34690347 [TBL] [Abstract][Full Text] [Related]
12. [COVID-19 vaccination at the University of Alicante (Spain): detection of neutralizing antibodies against SARS-CoV-2 by rapid serological test, a cross-sectional study]. Montagud AC; Vicente-Alcalde N; Gabaldón-Bravo EM; Hurtado-Sánchez JA; Montagud E; Egoavil CM; Chavarría-Alarcón E; Caballero P; Tuells J Rev Esp Salud Publica; 2023 Dec; 97():. PubMed ID: 38126466 [TBL] [Abstract][Full Text] [Related]
13. Factors associated with anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein antibody titer and neutralizing activity among healthcare workers following vaccination with the BNT162b2 vaccine. Kobashi Y; Shimazu Y; Kawamura T; Nishikawa Y; Omata F; Kaneko Y; Kodama T; Tsubokura M PLoS One; 2022; 17(6):e0269917. PubMed ID: 35687563 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Roche SARS-CoV-2 Rapid Antibody Test in Samples from Vaccinated Individuals. Hayer J; Urlaub E Microbiol Spectr; 2022 Jun; 10(3):e0270921. PubMed ID: 35575594 [TBL] [Abstract][Full Text] [Related]
15. [Investigation of SARS-CoV-2-Specific Humoral and Cellular Immunity Values in Health Care Workers with COVID-19 Disease and Administered with COVID-19 Vaccine]. Keskin AÜ; Dalan AB; Çıragil P; Topkaya AE Mikrobiyol Bul; 2022 Jul; 56(3):480-492. PubMed ID: 35960239 [TBL] [Abstract][Full Text] [Related]
16. Immunogenicity after two doses of inactivated virus vaccine in healthcare workers with and without previous COVID-19 infection: Prospective observational study. Yalçın TY; Topçu DI; Doğan Ö; Aydın S; Sarı N; Erol Ç; Kuloğlu ZE; Azap ÖK; Can F; Arslan H J Med Virol; 2022 Jan; 94(1):279-286. PubMed ID: 34468990 [TBL] [Abstract][Full Text] [Related]
17. Presence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies Among Vietnamese Healthcare Workers by Dosing Interval for ChAdOx1 nCoV-19 Vaccine. Vu DM; Vu DTB; Do TTT; Olmsted AE; Dao BH; Thai TT; Nguyen CL; Le NTT; Le TA; Bui HTT; Pham TN; Moore MR Clin Infect Dis; 2022 Oct; 75(Suppl 2):S174-S181. PubMed ID: 35723271 [TBL] [Abstract][Full Text] [Related]
18. Influencing factors of anti-SARS-CoV-2-spike-IgG antibody titers in healthcare workers: A cross-section study. Reusch J; Wagenhäuser I; Gabel A; Eggestein A; Höhn A; Lâm TT; Frey A; Schubert-Unkmeir A; Dölken L; Frantz S; Kurzai O; Vogel U; Krone M; Petri N J Med Virol; 2023 Jan; 95(1):e28300. PubMed ID: 36369641 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the Immunogenicity and Protective Efficacy of Various SARS-CoV-2 Vaccines among Healthcare Workers: Are Our White Coat Armies Protected? Souan L; Sughayer MA; Abualhour MM; Siag M; Al-Badr S; Al-Atrash T Vaccines (Basel); 2022 Apr; 10(5):. PubMed ID: 35632398 [TBL] [Abstract][Full Text] [Related]
20. [Antibody Response After Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthcare Workers with and without Previous COVID-19 Infection: A Prospective Observational Study]. Özgür D; Tütüncü EE Mikrobiyol Bul; 2022 Jan; 56(1):36-48. PubMed ID: 35088958 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]